ARBUTUS BIOPHARMA CORP COMMON (ABUS) Covered Calls

Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.

You can sell covered calls on ARBUTUS BIOPHARMA CORP COMMON to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ABUS (prices last updated Fri 4:16 PM ET):

ARBUTUS BIOPHARMA CORP COMMON (ABUS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
9.50 -0.45 9.40 10.65 233K - 0.5B
Covered Calls For ARBUTUS BIOPHARMA CORP COMMON (ABUS)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 10 0.50 10.15 -1.5% -18.9%
Dec 21 10 0.60 10.05 -0.5% -2.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Arbutus Biopharma Corp. is a biopharmaceutical company, which focuses on on discovering, developing and commercializing a cure for patients suffering from chronic HBV infection, a disease of the liver caused by the hepatitis B virus. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.